Big Pharma, Generics Activists Dispute Slows New TPP Agreement
This article was originally published in PharmAsia News
Executive Summary
A continuing dispute between major pharmaceutical companies and pro-generics activists has impeding the progress of the Trans-Pacific Partnership meeting in Singapore trying to develop a new agreement.